Aluminium and other Metals Exposure Cause Neurological Disorders: Evidence from Clinical/ human Studies
Book:
Biochemical Mechanisms of Aluminium Induced Neurological Disorders
Page:
97-146
Author(s):
Zehra Batool, Laraib Liaquat, Tuba Sharf Batool, Rida Nisar and Saida Haider*
Role of aluminium in Post-Translational Modifications and Neurological Disorders
Book:
Biochemical Mechanisms of Aluminium Induced Neurological Disorders
Page:
66-80
Author(s):
Saadia Zahid*, Sanila Amber and Fatima Javed Mirza
Biochemical Mechanisms of Aluminium and Other Metals Exposure, Their Brain Entry Mechanisms, Effects on Blood Brain Barrier and Important Pharmacokinetic Parameters in Neurological Disorders
Book:
Biochemical Mechanisms of Aluminium Induced Neurological Disorders
Page:
1-32
Author(s):
Sara Ishaq, Amna Liaqat, Armeen Hameed and Touqeer Ahmed*
Gene Therapy and Editing for the Treatment of Single-Gene Pain Disorders
Book:
Nanotherapeutic Strategies and New Pharmaceuticals (Part 2)
Page:
232-260
Author(s):
Fahad Hassan Shah, Song Ja Kim*, Jawaria Idrees, Muniba Tariq, Syed Haroon Khalid, Ikram Ullah Khan, Sajid Asghar and Saad Salman*
Sodium Channelopathies and Novel Viral/non-viral Vectors for their Gene Therapy
Book:
Nanotherapeutic Strategies and New Pharmaceuticals (Part 2)
Page:
207-231
Author(s):
Jawaria Idrees, Fahad Hassan Shah, Song Ja Kim, Muniba Tariq, Syed Haroon Khalid, Ikram Ullah Khan, Sajid Asghar and Saad Salman*
ADHD Comorbid to Substance Use Disorder: A Review of Genetics, Neurobiology, Brain Circuitry, and Nanotherapeutics
Book:
Nanotherapeutic Strategies and New Pharmaceuticals (Part 2)
Page:
161-206
Author(s):
Fahad Hassan Shah, Song Ja Kim*, Laiba Wasim, Shanza Nageen, Fakhra Sibtain, Muniba Tariq, Sajid Asghar and Saad Salman*
Nanotherapeutics for Treatment of Neurological Disorders
Book:
Nanotherapeutic Strategies and New Pharmaceuticals (Part 2)
Page:
1-15
Author(s):
Phoebe Wilson*
Monoclonal Antibodies as Therapeutic Agents for Inflammatory Diseases
Book:
Frontiers in Clinical Drug Research-Anti Infectives
Page:
1-54
Author(s):
Jéssica Bairos, Emanuel V. Capela*, Ana P.M. Tavares and Mara G. Freire
Comorbidities Inducing Mild Cognitive Impairment, an Evaluation of the Risk Caused by some Pathological Conditions
Book:
Frontiers in Clinical Drug Research-Dementia
Page:
1-55
Author(s):
Yolanda Cruz, Alejandra Romo, Roxana Rodríguez-Barrera, Almudena Chávez-Guerra, Macarena Fuentes and Antonio Ibarra*
Vitamin B12 (Cobalamin)
Book:
Hypersensitivity to Vitamins
Page:
67-81
Author(s):
Gianfranco Calogiuri